HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Rao Selected Research

Biomarkers (Surrogate Marker)

12/2021Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Rao Research Topics

Disease

44Leukemia
12/2022 - 06/2002
23Neoplasms (Cancer)
04/2024 - 07/2003
20Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 02/2003
8Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 12/2011
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 02/2003
3Acute Erythroblastic Leukemia (Erythroleukemia)
01/2024 - 01/2021
3Lymphoma (Lymphomas)
01/2023 - 09/2003
3Residual Neoplasm
03/2022 - 12/2011
3Acute Promyelocytic Leukemia
12/2021 - 06/2012
3Myeloid Leukemia (Leukemia, Myelocytic)
08/2015 - 01/2004
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2023 - 01/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 01/2019
2Genomic Instability
12/2021 - 06/2019
2Infections
12/2021 - 12/2015
2Lymphoid Leukemia
01/2019 - 09/2005
1Glucocorticoid Receptor Deficiency
04/2024
1Sarcoma (Soft Tissue Sarcoma)
04/2024
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2023
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1Bacterial Infections (Bacterial Infection)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Enterovirus Infections
12/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Dengue (Dengue Fever)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1B-Cell Leukemia (Leukemia, B Cell)
01/2019
1Inflammation (Inflammations)
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019
1Wilms Tumor (Wilm's Tumor)
09/2017

Drug/Important Bio-Agent (IBA)

12Chimeric Antigen ReceptorsIBA
11/2023 - 03/2016
10Proteins (Proteins, Gene)FDA Link
04/2024 - 02/2003
4CytokinesIBA
11/2023 - 01/2019
4Etoposide (VP 16)FDA LinkGeneric
08/2012 - 10/2008
4Messenger RNA (mRNA)IBA
02/2012 - 02/2003
3AntigensIBA
01/2023 - 03/2016
3Cadherins (E-Cadherin)IBA
05/2014 - 09/2008
3Interleukin-18 (Interleukin 18)IBA
01/2004 - 02/2003
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2024 - 06/2012
2calothrixin BIBA
01/2024 - 05/2021
2RNA (Ribonucleic Acid)IBA
10/2022 - 10/2008
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2021
2SesquiterpenesIBA
01/2022 - 07/2021
2Therapeutic UsesIBA
08/2021 - 01/2019
2Tyrosine Kinase InhibitorsIBA
08/2021 - 08/2005
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2015
2Interleukin-2 (IL2)IBA
01/2021 - 03/2016
2Daunorubicin (Cerubidine)FDA LinkGeneric
01/2020 - 09/2009
2Histone Deacetylase InhibitorsIBA
01/2018 - 05/2006
2LigandsIBA
01/2018 - 09/2003
2GTP Phosphohydrolases (GTPases)IBA
01/2016 - 10/2013
2Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 08/2005
2OligonucleotidesIBA
02/2011 - 02/2010
2Small Interfering RNA (siRNA)IBA
09/2009 - 09/2009
2Matrix Metalloproteinases (MMPs)IBA
01/2004 - 02/2003
2Macrophage Colony-Stimulating FactorIBA
07/2003 - 06/2002
1indoleIBA
04/2024
1GlucocorticoidsIBA
04/2024
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2024
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2024
1carbazoleIBA
01/2024
1AlkaloidsIBA
01/2024
1CD7 AntigensIBA
11/2023
1Phosphotransferases (Kinase)IBA
10/2023
1Bispecific AntibodiesIBA
07/2023
1AntibodiesIBA
07/2023
1HomoharringtonineIBA
01/2023
1Circular RNAIBA
12/2022
1Interleukin-1 (Interleukin 1)IBA
10/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1Inactivated VaccinesIBA
12/2021
1germacranolideIBA
07/2021
1Paris saponin VIIIBA
01/2021
1Incaspitolide AIBA
01/2021
1Interferon-gamma (Interferon, gamma)IBA
01/2021
1VaccinesIBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Interleukin-10 ReceptorsIBA
01/2021
1Glutathione PeroxidaseIBA
06/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2019
1GlycosidesIBA
04/2019
1compound 21IBA
04/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Monoclonal AntibodiesIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1Serine Proteases (Serine Protease)IBA
09/2017
1Prednisone (Sone)FDA LinkGeneric
08/2017

Therapy/Procedure

11Therapeutics
12/2022 - 09/2005
7Drug Therapy (Chemotherapy)
04/2024 - 10/2011
4Immunotherapy
10/2023 - 01/2019
2Transplantation
11/2018 - 05/2014
1Hematopoietic Stem Cell Transplantation
10/2023
1Aftercare (After-Treatment)
12/2022
1Traditional Medicine (Folk Remedies)
01/2022
1Intravenous Administration
05/2017